EHR, CDS can help improve childhood obesity treatment

EHR data can be for childhood obesity interventions, according to a study published in JAMA Pediatrics.

The study sought to determine how much clinical decision support (CDS) for pediatricians helped to improve body mass index (BMI) and care quality for obese children.

"Despite the availability of obesity management guidelines, interventions to improve BMI in children have not proved effective in the context of primary care, and pediatric clinicians have been slow to adopt recommended screening and management practices," the authors wrote.

Reliable clinical information systems could improve obesity management. "The use of electronic health records offers the potential for improving the quality of care for obese children and for accelerating the use of evidence on obesity screening and management by primary care clinicians," according to the study.

Elsie Taveras, MD, of Massachusetts General Hospital for Children in Boston, and colleagues tested child obesity interventions in a randomized three-arm clinical trial of 549 obese children aged 6-12 from 14 primary care practices. The patients were enrolled and tracked from October 2011 to June 2012.

One arm alerted clinicians to children with high BMIs and provided links to obesity screening guidelines, growth charts and information on weight management programs. Another provided this same level of support as well as a health coach to work with the patients' families by phone, text message and email. The third arm gave standards level of care with no CDS tools for treating obesity.

Those in the second arm experienced the greatest reductions in BMI. "We found that an intervention that leveraged efficient health information technology to provide CDS for pediatric clinicians and that provided an intervention for self-guided behavior change by families resulted in improvements in the children's BMI," the authors wrote.

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.